The Festival of Genomics & Biodata 2025 is just around the corner, and EIT Pathogena is thrilled to announce our participation in this event. Taking place on 29-30 January at the London ExCel, the festival brings together some of the brightest minds in genomics to explore innovations, discuss challenges, and shape the future of health technologies.

We are eager to share insights about our solutions, introduce our global network, and highlight our transformative work.

Spotlight on our CEO’s talk

Dr. Emma Stanton, our CEO, will present EIT Pathogena’s approach to an “Always On” global pathogen monitoring ecosystem during an engaging talk on 30th January. In the session, "Going Viral: Revolutionising Infectious Diseases Through Genomics," Dr. Stanton will explore the transformative potential of EIT Pathogena’s initiatives. From accelerating outbreak detection to delivering precise diagnostics and bridging critical global health gaps, this session will discuss cutting-edge advancements shaping the future of infectious disease management. She will also highlight the essential role of collaboration, demonstrating how partnerships across industry, government, and academia are making this bold vision a reality.

Experience Our Solutions

Visitors to our booth will have the opportunity to explore EIT Pathogena’s solutions, including:

• Automated Analysis Pipelines for Mycobacterium tuberculosis and SARS-CoV-2: Discover how our platform unlocks the potential of sequencing technologies by delivering automated, fast, and reliable pathogen analysis. We’ll be delighted to provide a live demo showcasing how our solutions streamline the process for impactful results.

• Learn About EIT Oxford: At EIT Pathogena, we are proud to be part of the Ellison Institute of Technology (EIT) Oxford, which is pursuing high-risk, high-reward, high-impact programmes to address some of humanity’s greatest challenges. Our team will walk you through EIT’s mission to lead and translate interdisciplinary scientific research into comprehensive solutions and policy frameworks that benefit society and drive global impact.

• Building Robust Networks: We are fostering collaborative networks that connect researchers, healthcare providers, and public health systems. These networks facilitate the seamless exchange of data, insights, and best practices worldwide, empowering a unified response to infectious disease threats.